rs72653173

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_000088.4(COL1A1):​c.3076C>T​(p.Arg1026*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000684 in 1,461,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

COL1A1
NM_000088.4 stop_gained

Scores

2
3
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:11O:1

Conservation

PhyloP100: 4.10
Variant links:
Genes affected
COL1A1 (HGNC:2197): (collagen type I alpha 1 chain) This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-50188765-G-A is Pathogenic according to our data. Variant chr17-50188765-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 35920.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-50188765-G-A is described in Lovd as [Pathogenic]. Variant chr17-50188765-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL1A1NM_000088.4 linkc.3076C>T p.Arg1026* stop_gained Exon 42 of 51 ENST00000225964.10 NP_000079.2 P02452
COL1A1XM_011524341.2 linkc.2878C>T p.Arg960* stop_gained Exon 39 of 48 XP_011522643.1
COL1A1XM_005257058.5 linkc.2806C>T p.Arg936* stop_gained Exon 40 of 49 XP_005257115.2
COL1A1XM_005257059.5 linkc.2158C>T p.Arg720* stop_gained Exon 29 of 38 XP_005257116.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL1A1ENST00000225964.10 linkc.3076C>T p.Arg1026* stop_gained Exon 42 of 51 1 NM_000088.4 ENSP00000225964.6 P02452
COL1A1ENST00000511732.1 linkn.20C>T non_coding_transcript_exon_variant Exon 1 of 2 2
COL1A1ENST00000486572.1 linkn.-211C>T upstream_gene_variant 3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461868
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:4
Oct 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

COL1A1: PVS1, PM2, PS4:Moderate -

Apr 27, 2021
Athena Diagnostics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is expected to result in the loss of a functional protein. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). This variant appears to segregate with disease in at least one family. In some published literature, this variant is referred to as R848X. -

Mar 21, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The COL1A1 c.3076C>T; p.Arg1026Ter variant (rs72653173), also known as p.Arg848Ter, is reported in the literature in multiple individuals and families affected with osteogenesis imperfecta type1 (Duan 2016, Ries 2000, Ries-Levavi 2004). This variant is reported in ClinVar (Variation ID: 35920) and is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Duan H et al. Identification of two recurrent mutations of COL1A1 gene in Chinese Van der Hoeve syndrome patients. Acta Otolaryngol. 2016 Aug;136(8):786-91. PMID: 27044453. Ries L et al. Prenatal diagnosis of a novel COL1A1 mutation in osteogenesis imperfecta type I carried through full term pregnancy. Prenat Diagn. 2000 Nov;20(11):876-80. PMID: 11113887. Ries-Levavi L et al. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients. Hum Mutat. 2004 Apr;23(4):399-400. PMID: 15024745. -

Dec 26, 2024
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26627451, 36709916, 37079061, 37334733, 37270749, 35909573, 34902613, 36951356, 29499418, 28396251, 15024745, 17392686, 23682531, 27044453, 22753364, 24767406, 15241796, 31447884, 30692697, 30715774, 32770541, 34358384, 32166892, 37810882, 38807347, 11113887, 21667357) -

Osteogenesis imperfecta Pathogenic:2
Aug 01, 2018
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 18, 2018
Baylor Genetics
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Osteogenesis imperfecta type I Pathogenic:2
Sep 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change creates a premature translational stop signal (p.Arg1026*) in the COL1A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL1A1 are known to be pathogenic (PMID: 7942841, 9295084, 9443882). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with osteogenesis imperfecta, type 1 (PMID: 11113887, 27044453). ClinVar contains an entry for this variant (Variation ID: 35920). For these reasons, this variant has been classified as Pathogenic. -

Feb 25, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: COL1A1 c.3076C>T (p.Arg1026X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251366 control chromosomes. c.3076C>T has been reported in the literature in multiple individuals affected with Osteogenesis imperfecta type I (example: Hartikka_2004, Ries_2000, Ries-Levavi_2004). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. Specifically, it was demonstrated that the variant resulted in a significant reduction in COL1A1 mRNA production (example: Kaneto_2014). The following publications have been ascertained in the context of this evaluation (PMID: 15241796, 24767406, 15024745, 11113887). ClinVar contains an entry for this variant (Variation ID: 35920). Based on the evidence outlined above, the variant was classified as pathogenic. -

Infantile cortical hyperostosis;C0023931:Osteogenesis imperfecta type I;C0029456:Osteoporosis;C0268358:Osteogenesis imperfecta, perinatal lethal;C0268362:Osteogenesis imperfecta type III;C0268363:Osteogenesis imperfecta with normal sclerae, dominant form;C4551623:Ehlers-Danlos syndrome, arthrochalasia type;C5436842:Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 Pathogenic:1
May 05, 2022
Fulgent Genetics, Fulgent Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Abnormality of the skeletal system Pathogenic:1
Jul 10, 2021
Kariminejad - Najmabadi Pathology & Genetics Center
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

COL1A1-related disorder Pathogenic:1
Sep 27, 2024
PreventionGenetics, part of Exact Sciences
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

The COL1A1 c.3076C>T variant is predicted to result in premature protein termination (p.Arg1026*). This variant has been reported in multiple unrelated individuals with osteogenesis imperfecta type 1 (for example, see : Ries-Levavi et al. 2004. PubMed ID: 15024745; Hartikka et al. 2004. PubMed ID: 15241796; Table S1, Li et al. 2019. PubMed ID: 30715774). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in COL1A1 are expected to be pathogenic. This variant is interpreted as pathogenic. -

Infantile cortical hyperostosis;C0029434:Osteogenesis imperfecta;C4551623:Ehlers-Danlos syndrome, arthrochalasia type Other:1
-
GenomeConnect - Invitae Patient Insights Network
Significance: not provided
Review Status: no classification provided
Collection Method: phenotyping only

Variant interpreted as Pathogenic and reported on 06-26-2020 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.60
D
BayesDel_noAF
Pathogenic
0.53
CADD
Pathogenic
37
DANN
Uncertain
1.0
Eigen
Uncertain
0.38
Eigen_PC
Benign
0.14
FATHMM_MKL
Uncertain
0.91
D
Vest4
0.95
GERP RS
1.6

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72653173; hg19: chr17-48266126; API